Refine Search
(0)
(1)
(12)
(14)

Fibrinogen Deficiency (Factor I Deficiency) - Pipeline Review, H2 2016

  • $2,000
  • August 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Fibrinogen Deficiency (Factor I Deficiency) - Pipeline Review, H2 2016’, provides an overview of the Fibrinogen Deficiency (Factor I Deficiency) pipeline landscape.

The report provides comprehensive information ...

Febrile Neutropenia - Pipeline Review, H2 2016

  • $2,000
  • October 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Febrile Neutropenia - Pipeline Review, H2 2016’, provides an overview of the Febrile Neutropenia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Febril...

Thrombocytopenia - Pipeline Review, H2 2016

  • $2,000
  • November 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Thrombocytopenia - Pipeline Review, H2 2016’, provides an overview of the Thrombocytopenia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Thrombocytop...

Hemorrhage - Pipeline Review, H2 2017

  • $2,000
  • August 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hemorrhage - Pipeline Review, H2 2017’, provides an overview of the Hemorrhage pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hemorrhage, complete wit...

Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2018’, provides an overview of the Anemia in Chronic Kidney Disease (Renal Anemia) pipeline landscape.

The report provides comprehensive info...

Hemophilia B - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hemophilia B - Pipeline Review, H2 2018’, provides an overview of the Hemophilia B pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hemophilia B, comple...

Neutropenia - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Neutropenia - Pipeline Review, H2 2018’, provides an overview of the Neutropenia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Neutropenia, complete ...

Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2018’, provides an overview of the Paroxysmal Nocturnal Hemoglobinuria pipeline landscape.

The report provides comprehensive information on the therapeut...

Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Thrombotic Thrombocytopenic Purpura - Pipeline Review, H2 2018’, provides an overview of the Thrombotic Thrombocytopenic Purpura pipeline landscape.

The report provides comprehensive information on the therapeut...

Sickle Cell Disease - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Sickle Cell Disease - Pipeline Review, H2 2018’, provides an overview of the Sickle Cell Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Sickle...

Thalassemia - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Thalassemia - Pipeline Review, H2 2018’, provides an overview of the Thalassemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Thalassemia, complete ...

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H2 2018’, provides an overview of the Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) pipeline landscape. <...

Hemophilia A - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hemophilia A - Pipeline Review, H2 2018’, provides an overview of the Hemophilia A pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hemophilia A, comple...

Fanconi Anemia - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Fanconi Anemia - Pipeline Review, H2 2018’, provides an overview of the Fanconi Anemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Fanconi Anemia, ...

Hypereosinophilic Syndrome - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hypereosinophilic Syndrome - Pipeline Review, H2 2018’, provides an overview of the Hypereosinophilic Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under developm...